They are not FDA-approved for weight loss
GLP-3 RT is an investigational triple-agonist peptide designed to simultaneously activate GLP-1, GIP, and Glucagon receptors
COJEC drugs: cisplatin (Santa Cruz Biotechnology, sc-200896), vincristine (Santa Cruz Biotechnology, sc-201434), etoposide (Santa Cruz Biotechnology, sc-3512), cyclophosphamide (Santa Cruz Biotechnology, sc-361165), and carboplatin (Santa Cruz Biotechnology, sc-202093A)
and (ii) proliferative astrogliosis, which is anisomorphic with loss of domain, substantial structural reorganisation and can either be diffuse or can result in the formation of new compact limitans borders around overt fibrotic tissue lesions (Fig
Peptide therapy should always be medically supervised
We're not just mixing ingredients